Tolerability and toxicity of pegaspargase in adults 40 years and older with acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Tolerability and toxicity of pegaspargase in adults 40 years and older with acute lymphoblastic leukemia

Published:2020-09-26 Issue:1 Volume:62 Page:176-184
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Daley Ryan J.¹^ORCID,Rajeeve Sridevi²,Kabel Charlene C.¹,Pappacena Jeremy J.³,Stump Sarah E.¹,Lavery Jessica A.⁴,Tallman Martin S.⁵,Geyer Mark B.⁵^ORCID,Park Jae H.⁵

Affiliation:

1. Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, USA

2. Department of Medicine, Icahn School of Medicine/Mount Sinai St. Luke’s-West Hospital, New York, NY, USA

3. Department of Pharmacy, Allegheny Health Network, Pittsburgh, PA, USA

4. Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA

5. Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1824068

Reference25 articles.

1. National Comprehensive Cancer Network (NCCN). Acute lymphoblastic leukemia (Version 1.2018). National Comprehensive Cancer Network; 2018. Available from: https://www.nccn.org/professionals/physician_gls/pdf/all.pdf

2. Overall survival among older US adults with ALL remains low despite modest improvement since 1980: SEER analysis

3. Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century

4. What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies

5. Should Adolescents With Acute Lymphoblastic Leukemia Be Treated as Old Children or Young Adults? Comparison of the French FRALLE-93 and LALA-94 Trials

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HyperCVAD versus pegaspargase‐containing regimens for Hispanic adults with newly diagnosed B‐cell acute lymphoblastic leukemia;European Journal of Haematology;2023-11-06

2. Evaluating the efficacy and toxicity of dose adjusted pegylated L-asparaginase in combination with therapeutic drug monitoring;Annals of Hematology;2023-07-22

3. Increased incidence of Pegaspargase-induced hypertriglyceridemia and associated pancreatitis observed in the Hispanic adult patient population;Leukemia & Lymphoma;2022-07-14

4. Asparaginase in the Treatment of Acute Lymphoblastic Leukemia in Adults: Current Evidence and Place in Therapy;Blood and Lymphatic Cancer: Targets and Therapy;2022-05

5. L-Asparaginase-Induced Hepatotoxicity Treated Successfully With L-Carnitine and Vitamin B Infusion;Cureus;2021-08-05